Trough levels of adalimumab and the appearances of anti-adalimumab antibody in non-infectious uveitis patients treated with Adalimumab

被引：0
|
作者：
Suzuki, K. [1 ]
Iwata, D. [1 ]
Namba, K. [1 ]
Mizuuchi, K. [1 ]
Fukuhara, T. [1 ]
Ohno, S. [1 ]
Kitaichi, N. [1 ]
Ishida, S. [1 ]
机构：
[1] Hokkaido Univ, Sapporo, Hokkaido, Japan
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P051
引用
收藏
页码：S174 / S174
页数：1
相关论文
共 50 条
  • [1] Risk factors for development of anti-adalimumab antibodies in non-infectious uveitis
    Bromeo, Albert John
    Karaca, Irmak
    Ghoraba, Hashem H.
    Lyu, Xun
    Trong, Ngoc
    Than, Tuong
    Ongpalakorn, Prapatsorn
    Shin, Yong Un
    Uludag, Gunay
    Tran, Anh Ngoc Tram
    Thng, Zheng Xian
    V. Do, Diana
    Mong, Chi
    Or, Christopher
    Nguyen, Quan Dong
    [J]. HELIYON, 2024, 10 (09)
  • [2] Risk factors for development of anti-adalimumab antibodies in non-infectious uveitis
    Bromeo, Albert
    Karaca, Irmak
    Ghoraba, Hashem
    Lyu, Xun
    Akhavanrezayat, Amir
    Uludag, Gunay
    Than, Ngoc
    Ongpalakorn, Prapatsorn
    Shin, YongUn
    Tran, Anh
    Yavari, Negin
    Khojasteh, Hassan
    Bazojoo, Vahid
    Ahmed, Mohamed
    Or, Chris
    Nguyen, Quan
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [3] Adalimumab in the treatment of non-infectious uveitis
    Burek-Michalska, Alicja
    Turno-Krecicka, Anna
    [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 29 (10): : 1231 - 1236
  • [4] Adalimumab in Patients with Active and Inactive Non-infectious Uveitis
    Ohno, S.
    Nguyen, Q. D.
    Dick, A.
    Jaffe, G.
    Brezin, A.
    Song, A. P.
    Kron, M.
    Camez, A.
    Tari, S.
    [J]. SWISS MEDICAL WEEKLY, 2016, 146 : 8S - 8S
  • [5] The influence of anti-adalimumab antibodies on adalimumab trough levels, TNF-α levels and clinical outcome
    Bodini, G.
    Savarino, V.
    Dulbecco, P.
    Baldissarro, I.
    Savarino, E.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S42 - S42
  • [6] The effectiveness of adalimumab treatment for non-infectious uveitis
    Hasegawa, Eiichi
    Takeda, Atsunobu
    Yawata, Nobuyo
    Sonoda, Koh-Hei
    [J]. IMMUNOLOGICAL MEDICINE, 2019, 42 (02) : 79 - 83
  • [7] Anti-adalimumab Antibodies in Patients with Non-infectious Ocular Inflammatory Disease: A Case Series
    McKay, K. Matthew
    Apostolopoulos, Nicholas
    Chou, Brian
    Leveque, Thellea K.
    Van Gelder, Russell N.
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2022, 30 (7-8) : 1721 - 1725
  • [8] Early Adalimumab and Anti-Adalimumab Antibody Levels for Prediction of Primary Nonresponse in Ankylosing Spondylitis Patients
    Ding, Xiaoliang
    Zhu, Ruifang
    Wu, Jian
    Xue, Ling
    Gu, Meihua
    Miao, Liyan
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (03): : 547 - 554
  • [9] Adalimumab treatment in adult patients with refractory non-infectious uveitis
    Esen, Ebru
    Isik, Puren
    Sizmaz, Selcuk
    Demircan, Nihal
    [J]. CUKUROVA MEDICAL JOURNAL, 2023, 48 (02): : 457 - 462
  • [10] ADALIMUMAB TROUGH LEVELS AND ANTI-ADALIMUMAB ANTIBODIES CORRELATE WITH CLINICAL AND ENDOSCOPIC ACTIVITY IN CROHN'S DISEASE PATIENTS
    Pellegatta, G.
    Lo Pumo, S.
    Bodini, G.
    Baldissarro, I.
    Giannini, E. G. B.
    Savarino, V.
    Jain, A.
    Savarino, E.
    [J]. DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E135 - E135
12345